Arthur F Ryan

Director, Regeneron Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$0.4M

Companies

Latest trade

Jul 2, 2026

Companies

Regeneron PharmaceuticalsDirector −$0.4M

Trades

REGN Sold 200 shares at $650.15 · planned $0.1M Jul 2

REGN Sold 100 shares at $705.24 · planned $0.1M May 1

REGN Sold 100 shares at $777.27 · planned $0.1M Apr 1

REGN Sold 100 shares at $785.50 · planned $0.1M Mar 2

REGN Sold 100 shares at $778.53 · planned $0.1M Feb 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.